Results 231 to 240 of about 88,519 (382)
Assessment of anxiety and health-related quality of life in patients with lower extremity peripheral arterial occlusive disease. [PDF]
Guzelhan Y +8 more
europepmc +1 more source
The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease.
H. Stoffers +4 more
semanticscholar +1 more source
Abstract Background and Purpose Plasma glucocorticoids increase acutely after MI, thereafter tissue levels are amplified selectively within cells expressing 11‐ßhydroxysteroid dehydrogenase type 1 (11‐ßHSD1) that regenerates active glucocorticoids from circulating metabolites.
Sara Al Disi +19 more
wiley +1 more source
End points for sickle cell disease clinical trials: Patient-reported outcomes, pain, and the brain [PDF]
al., et +2 more
core +1 more source
S1‐Guideline for diagnosis and therapy of necrobiosis lipoidica
Summary Necrobiosis lipoidica (NL) is a rare granulomatous skin disease of unknown etiology that occurs frequently in association with diabetes mellitus and other comorbidities. The predilection site is the lower leg, particularly the pretibial areas. The exact pathogenesis remains unclear.
Cornelia Erfurt‐Berge +6 more
wiley +1 more source
[What is new in the management of peripheral arterial occlusive disease and diseases of the aorta? : Highlights of the ESC guidelines 2024]. [PDF]
Schulze-Bauer H +3 more
europepmc +1 more source
Endovascular Surgery for Peripheral Arterial Occlusive Disease
Samuel S. Ahn +2 more
openalex +2 more sources
Peripheral Arterial Occlusive Disease: Diagnostic Performance and Effect on Therapeutic Management of 64-Section CT Angiography [PDF]
Alessandro Napoli +9 more
openalex +1 more source

